<DOC>
	<DOCNO>NCT02815839</DOCNO>
	<brief_summary>The objective study ass safety , tolerance , food effect , pharmacokinetic pharmacodynamic property single dose adminstration SHR4640 healthy volunteer .</brief_summary>
	<brief_title>Single Dose Study SHR4640 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hyperuricemia</mesh_term>
	<criteria>Body weight≥50 , BMI:1924kg/m2 ; Screening serum urate level ≤ 4.5 mg/dL male ≤ 3.5 mg/dL female ; Medically stable base physical examination , medical history , laboratory result , vital sign measurement , 12lead electrocardiogram ( ECG ) screening ; History hyperuricemia gout . Pregnancy breastfeed ; History suspicion kidney stone ; serum creatinine＞1.5mg/dl male , ＞1.2mg/dl female ; alanine aminotransferase and/or aspartate aminotransferase＞2 upper limit normal , total bilirubin＞2.5 upper limit normal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>urate transporter 1</keyword>
	<keyword>SHR4640</keyword>
	<keyword>single ascend dose</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>